Document:

exv4w4

Exhibit 4.4

DISCOVERY COMMUNICATIONS, INC.

2005 NON-EMPLOYEE DIRECTOR INCENTIVE PLAN

(As Amended and Restated)

ARTICLE I

Purpose and Amendment of Plan

     1.1 Purpose. The purpose of the Plan is to provide a method whereby eligible Nonemployee
Directors of the Company may be awarded additional remuneration for services rendered and
encouraged to invest in capital stock of the Company, thereby increasing their proprietary interest
in the Company’s businesses and increasing their personal interest in the continued success and
progress of the Company. The Plan is also intended to aid in attracting Persons of exceptional
ability to become Nonemployee Directors of the Company.

     1.2 Amendment and Restatement of Plan. The Plan is hereby amended and restated as of September
17, 2008 by the Board of the Company.

ARTICLE II

Definitions

     2.1 Certain Defined Terms. Capitalized terms not defined elsewhere in the Plan shall have the
following meanings (whether used in the singular or plural):

     “Affiliate” of the Company means any corporation, partnership or other business association
that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is
under common control with the Company.

     “Agreement” means a stock option agreement, stock appreciation rights agreement, restricted
shares agreement, stock units agreement or an agreement evidencing more than one type of Award,
specified in Section 10.5, as any such Agreement may be supplemented or amended from time to time.

     “Approved Transaction” means any transaction in which the Board (or, if approval of the Board
is not required as a matter of law, the stockholders of the Company) shall approve (i) any
consolidation or merger of the Company, or binding share exchange, pursuant to which shares of
Common Stock of the Company would be changed or converted into or exchanged for cash, securities or
other property, other than any such transaction in which the common stockholders of the Company
immediately prior to such transaction have the same proportionate ownership of the Common Stock of,
and voting power with respect to, the surviving corporation immediately after such transaction,
(ii) any merger, consolidation or binding share exchange to which the Company is a party as a
result of which the Persons who are common stockholders of the Company immediately prior thereto
have less than a majority of the combined voting power of the outstanding capital stock of the
Company ordinarily (and apart from the rights accruing under special circumstances) having the
right to vote in the election of directors immediately following such merger, consolidation or
binding share exchange, (iii) the adoption of any plan or proposal for the liquidation or
dissolution of the Company, or (iv) any sale, lease, exchange or other
transfer (in one transaction or a series of related transactions) of all, or substantially all, of
the assets of the Company.

-1-

 

     “Award” means a grant of Options, SARs, Restricted Shares, Stock Units and/or cash under the
Plan.

     “Board” means the Board of Directors of the Company.

     “Board Change” means, during any period of two consecutive years, individuals who at the
beginning of such period constituted the entire Board cease for any reason to constitute a majority
thereof unless the election, or the nomination for election, of each new director was approved by a
vote of at least two-thirds of the directors then still in office who were directors at the
beginning of the period.

     “Code” means the Internal Revenue Code of 1986, as amended from time to time, or any successor
statute or statutes thereto. Reference to any specific Code section shall include any successor
section.

     “Common Stock” means each or any (as the context may require) series of the Company‘s common
stock.

     “Company” means Discovery Communications, Inc., a Delaware corporation.

     “Control Purchase” means any transaction (or series of related transactions) in which (i) any
person (as such term is defined in Sections 13(d)(3) and 14(d)(2) of the Exchange Act), corporation
or other entity (other than the Company, any Subsidiary of the Company or any employee benefit plan
sponsored by the Company or any Subsidiary of the Company) shall purchase any Common Stock of the
Company (or securities convertible into Common Stock of the Company) for cash, securities or any
other consideration pursuant to a tender offer or exchange offer, without the prior consent of the
Board, or (ii) any person (as such term is so defined), corporation or other entity (other than the
Company, any Subsidiary of the Company, any employee benefit plan sponsored by the Company or any
Subsidiary of the Company or any Exempt Person (as defined below)) shall become the “beneficial
owner” (as such term is defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of the Company representing 20% or more of the combined voting power of the then
outstanding securities of the Company ordinarily (and apart from the rights accruing under special
circumstances) having the right to vote in the election of directors (calculated as provided in
Rule 13d-3(d) under the Exchange Act in the case of rights to acquire the Company’s securities),
other than in a transaction (or series of related transactions) approved by the Board. For purposes
of this definition, “Exempt Person” means each of (a) the Chairman of the Board, the President and
each of the directors of Discovery Holding Company as of the Distribution Date, and (b) the
respective family members, estates, and heirs of each of the persons referred to in clause (a)
above and any trust or other investment vehicle for the primary benefit of any of such persons or
their respective family members or heirs. As used with respect to any person, the term “family
member” means the spouse, siblings and lineal descendants of such person.

-2-

 

     “Disability” means the inability to engage in any substantial gainful activity by reason of
any medically determinable physical or mental impairment which can be expected to result in death
or which has lasted or can be expected to last for a continuous period of not less than 12 months.

     “Distribution Date” means the date on which the Company ceased to be a wholly-owned subsidiary
of Liberty Media Corporation, a Delaware corporation.

     “Dividend Equivalents” means, with respect to Restricted Shares to be issued at the end of the
Restriction Period, to the extent specified by the Board only, an amount equal to all dividends and
other distributions (or the economic equivalent thereof) which are payable to stockholders of
record during the Restriction Period on a like number and kind of shares of Common Stock.

     “Domestic Relations Order” means a domestic relations order as defined by the Code or Title I
of the Employee Retirement Income Security Act, or the rules thereunder.

     “Effective Date” means May 3, 2005, the date on which the Plan originally became effective.

     “Equity Security” shall have the meaning ascribed to such term in Section 3(a)(11) of the
Exchange Act, and an equity security of an issuer shall have the meaning ascribed thereto in Rule
16a-1 promulgated under the Exchange Act, or any successor Rule.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any
successor statute or statutes thereto. Reference to any specific Exchange Act section shall include
any successor section.

     “Fair Market Value” of a share of any series of Common Stock on any day means the last sale
price (or, if no last sale price is reported, the average of the high bid and low asked prices) for
a share of such series of Common Stock on such day (or, if such day is not a trading day, on the
next preceding trading day) as reported on the consolidated transaction reporting system for the
principal national securities exchange on which shares of such series of Common Stock are listed on
such day or if such shares are not then listed on a national securities exchange, then as reported
on Nasdaq. If for any day the Fair Market Value of a share of the applicable series of Common Stock
is not determinable by any of the foregoing means, then the Fair Market Value for such day shall be
determined in good faith by the Board on the basis of such quotations and other considerations as
the Board deems appropriate.

     “Free Standing SAR” has the meaning ascribed thereto in Section 7.1.

     “Holder” means a person who has received an Award under the Plan.

     “Nasdaq” means The NASDAQ Stock Market.

     “Nonemployee Director” means an individual who is a member of the Board and who is not an
employee of the Company or any Subsidiary.

     “Nonqualified Stock Option” means a stock option granted under Article VI.

-3-

 

     “Option” means a Nonqualified Stock Option.

     “Person” means an individual, corporation, limited liability company, partnership, trust,
incorporated or unincorporated association, joint venture or other entity of any kind.

     “Plan” means this Discovery Communications, Inc. 2005 Non-Employee Director Incentive Plan.”

     “Restricted Shares” means shares of any series of Common Stock or the right to receive shares
of any specified series of Common Stock, as the case may be, awarded pursuant to Article VIII.

     “Restriction Period” means a period of time beginning on the date of each Award of Restricted
Shares and ending on the Vesting Date with respect to such Award.

     “Retained Distribution” has the meaning ascribed thereto in Section 8.3.

     “SARs” means stock appreciation rights, awarded pursuant to Article VII, with respect to
shares of any specified series of Common Stock.

     “Stock Unit Awards” has the meaning ascribed thereto in Section 9.1.

     “Subsidiary” of a Person means any present or future subsidiary (as defined in Section 424(f)
of the Code) of such Person or any business entity in which such Person owns, directly or
indirectly, 50% or more of the voting, capital or profits interests. An entity shall be deemed a
subsidiary of a Person for purposes of this definition only for such periods as the requisite
ownership or control relationship is maintained.

     “Tandem SARs” has the meaning ascribed thereto in Section 7.1.

     “Vesting Date,” with respect to any Restricted Shares awarded hereunder, means the date on
which such Restricted Shares cease to be subject to a risk of forfeiture, as designated in or
determined in accordance with the Agreement with respect to such Award of Restricted Shares
pursuant to Article VIII. If more than one Vesting Date is designated for an Award of Restricted
Shares, reference in the Plan to a Vesting Date in respect of such Award shall be deemed to refer
to each part of such Award and the Vesting Date for such part.

ARTICLE III

Administration

     3.1 Administration. The Plan shall be administered by the Board, provided that it may delegate
to employees of the Company certain administrative or ministerial duties in carrying out the
purposes of the Plan.

-4-

 

     3.2 Powers. The Board shall have full power and authority to grant to eligible persons Options
under Article VI of the Plan, SARs under Article VII of the Plan, Restricted Shares under Article
VIII of the Plan and/or Stock Units under Article IX of the Plan, to determine the terms and
conditions (which need not be identical) of all Awards so granted, to interpret the provisions of
the Plan and any Agreements relating to Awards granted under the Plan and to supervise the
administration of the Plan. The Board in making an Award may provide for the granting or issuance
of additional, replacement or alternative Awards upon the occurrence of specified events, including
the exercise of the original Award. The Board shall have sole authority in the selection of persons
to whom Awards may be granted under the Plan and in the determination of the timing, pricing, and
amount of any such Award, subject only to the express provisions of the Plan. In making
determinations hereunder, the Board may take into account such factors as the Board in its
discretion deems relevant.

     3.3 Interpretation. The Board is authorized, subject to the provisions of the Plan, to
establish, amend and rescind such rules and regulations as it deems necessary or advisable for the
proper administration of the Plan and to take such other action in connection with or in relation
to the Plan as it deems necessary or advisable. Each action and determination made or taken
pursuant to the Plan by the Board, including any interpretation or construction of the Plan, shall
be final and conclusive for all purposes and upon all persons. No member of the Board shall be
liable for any action or determination made or taken by him or the Board in good faith with respect
to the Plan.

ARTICLE IV

Shares Subject to the Plan

     4.1 Number of Shares. Subject to the provisions of this Article IV, the maximum number of
shares of Common Stock with respect to which Awards may be granted during the term of the Plan
shall be 5 million shares. Shares of Common Stock will be made available from the authorized but
unissued shares of the Company or from shares reacquired by the Company, including shares purchased
in the open market. The shares of Common Stock subject to (a) any Award granted under the Plan that
shall expire, terminate or be annulled for any reason without having been exercised (or considered
to have been exercised as provided in Section 7.2), (b) any Award of any SARs granted under the
Plan that shall be exercised for cash, and (c) any Award of Restricted Shares or Stock Units that
shall be forfeited prior to becoming vested (provided that the Holder received no benefits of
ownership of such Restricted Shares or Stock Units other than voting rights and the accumulation of
Retained Distributions and unpaid Dividend Equivalents that are likewise forfeited) shall again be
available for purposes of the Plan.

-5-

 

     4.2 Adjustments. If the Company subdivides its outstanding shares of any series of Common
Stock into a greater number of shares of such series of Common Stock (by stock dividend, stock
split, reclassification, or otherwise) or combines its outstanding shares of any series of Common
Stock into a smaller number of shares of such series of Common Stock (by reverse stock split,
reclassification, or otherwise) or if the Board determines that any stock dividend, extraordinary
cash dividend, reclassification, recapitalization, reorganization, split-up, spin-off, combination,
exchange of shares, warrants or rights offering to purchase such series of Common Stock or other
similar corporate event (including mergers or consolidations other than those which
constitute Approved Transactions, adjustments with respect to which shall be governed by Section
10.1(b)) affects any series of Common Stock so that an adjustment is required to preserve the
benefits or potential benefits intended to be made available under the Plan, then the Board, in
such manner as the Board, in its sole discretion, deems equitable and appropriate, shall make such
adjustments to any or all of (a) the number and kind of shares of stock which thereafter may be
awarded, optioned, or otherwise made subject to the benefits contemplated by the Plan, (b) the
number and kind of shares of stock subject to outstanding Awards, and (c) the purchase or exercise
price and the relevant appreciation base with respect to any of the foregoing, provided, however,
that the number of shares subject to any Award shall always be a whole number. Notwithstanding the
foregoing, if all shares of any series of Common Stock are redeemed, then each outstanding Award
shall be adjusted to substitute for the shares of such series of Common Stock subject thereto the
kind and amount of cash, securities or other assets issued or paid in the redemption of the
equivalent number of shares of such series of Common Stock and otherwise the terms of such Award,
including, in the case of Options or similar rights, the aggregate exercise price, and, in the case
of Free Standing SARs, the aggregate base price, shall remain constant before and after the
substitution (unless otherwise determined by the Board and provided in the applicable Agreement).
The Board may, if deemed appropriate, provide for a cash payment to any Holder of an Award in
connection with any adjustment made pursuant to this Section 4.2.

ARTICLE V

Eligibility

     5.1 General. The persons who shall be eligible to participate in the Plan and to receive
Awards under the Plan shall, subject to Section 5.2, be such persons who are Nonemployee Directors
as the Board shall select. Awards may be made to Nonemployee Directors who hold or have held Awards
under the Plan or any similar or other awards under any other plan of the Company or any of its
Affiliates.

     5.2 Ineligibility. No person who is not a Nonemployee Director shall be eligible to receive an
Award.

ARTICLE VI

Stock Options

     6.1 Grant of Options. Subject to the limitations of the Plan, the Board shall designate from
time to time those eligible persons to be granted Options, the time when each Option shall be
granted to such eligible persons, the series and number of shares of Common Stock subject to such
Option, and, subject to Section 6.2, the purchase price of the shares of Common Stock subject to
such Option.

     6.2 Option Price. The price at which shares may be purchased upon exercise of an Option shall
be fixed by the Board and may be no less than the Fair Market Value of the shares of the applicable
series of Common Stock subject to the Option as of the date the Option is granted.

-6-

 

     6.3 Term of Options. Subject to the provisions of the Plan with respect to death, retirement
and termination of service, the term of each Option shall be for such period as the Board shall
determine as set forth in the applicable Agreement.

     6.4 Exercise of Options. An Option granted under the Plan shall become (and remain)
exercisable during the term of the Option to the extent provided in the applicable Agreement and
the Plan and, unless the Agreement otherwise provides, may be exercised to the extent exercisable,
in whole or in part, at any time and from time to time during such term; provided, however, that
subsequent to the grant of an Option, the Board, at any time before complete termination of such
Option, may accelerate the time or times at which such Option may be exercised in whole or in part
(without reducing the term of such Option).

     6.5 Manner of Exercise.

     (a) Form of Payment. An Option shall be exercised by written notice to the Company upon such
terms and conditions as the Agreement may provide and in accordance with such other procedures for
the exercise of Options as the Board may establish from time to time. The method or methods of
payment of the purchase price for the shares to be purchased upon exercise of an Option and of any
amounts required by Section 10.9 shall be determined by the Board and may consist of (i) cash, (ii)
check, (iii) whole shares of any series of Common Stock, (iv) the withholding of shares of the
applicable series of Common Stock issuable upon such exercise of the Option, (v) the delivery,
together with a properly executed exercise notice, of irrevocable instructions to a broker to
deliver promptly to the Company the amount of sale or loan proceeds required to pay the purchase
price, or (vi) any combination of the foregoing methods of payment, or such other consideration and
method of payment as may be permitted for the issuance of shares under the Delaware General
Corporation Law. The permitted method or methods of payment of the amounts payable upon exercise of
an Option, if other than in cash, shall be set forth in the applicable Agreement and may be subject
to such conditions as the Board deems appropriate.

     (b) Value of Shares. Unless otherwise determined by the Board and provided in the applicable
Agreement, shares of any series of Common Stock delivered in payment of all or any part of the
amounts payable in connection with the exercise of an Option, and shares of any series of Common
Stock withheld for such payment, shall be valued for such purpose at their Fair Market Value as of
the exercise date.

     (c) Issuance of Shares. The Company shall effect the transfer of the shares of Common Stock
purchased under the Option as soon as practicable after the exercise thereof and payment in full of
the purchase price therefor and of any amounts required by Section 10.9, and within a reasonable
time thereafter, such transfer shall be evidenced on the books of the Company. Unless otherwise
determined by the Board and provided in the applicable Agreement, (i) no Holder or other person
exercising an Option shall have any of the rights of a stockholder of the Company with respect to
shares of Common Stock subject to an Option granted under the Plan until due exercise and full
payment has been made, and (ii) no adjustment shall be made for cash dividends or other rights for
which the record date is prior to the date of such due exercise and full payment.

-7-

 

     6.6 Nontransferability. Unless otherwise determined by the Board and provided in the
applicable Agreement, Options shall not be transferable other than by will or the laws of descent
and distribution or pursuant to a Domestic Relations Order, and, except as otherwise required
pursuant to a Domestic Relations Order, Options may be exercised during the lifetime of the Holder
thereof only by such Holder (or his or her court-appointed legal representative).

ARTICLE VII

SARs

     7.1 Grant of SARs. Subject to the limitations of the Plan, SARs may be granted by the Board to
such eligible persons in such numbers, with respect to any specified series of Common Stock, and at
such times during the term of the Plan as the Board shall determine. A SAR may be granted to a
Holder of an Option (hereinafter called a “related Option”) with respect to all or a portion of the
shares of Common Stock subject to the related Option (a “Tandem SAR”) or may be granted separately
to an eligible Nonemployee Director (a “Free Standing SAR”). Subject to the limitations of the
Plan, SARs shall be exercisable in whole or in part upon notice to the Company upon such terms and
conditions as are provided in the Agreement.

     7.2 Tandem SARs. A Tandem SAR may be granted either concurrently with the grant of the related
Option or at any time thereafter prior to the complete exercise, termination, expiration or
cancellation of such related Option. Tandem SARs shall be exercisable only at the time and to the
extent that the related Option is exercisable (and may be subject to such additional limitations on
exercisability as the Agreement may provide) and in no event after the complete termination or full
exercise of the related Option. Upon the exercise or termination of the related Option, the Tandem
SARs with respect thereto shall be canceled automatically to the extent of the number of shares of
Common Stock with respect to which the related Option was so exercised or terminated. Subject to
the limitations of the Plan, upon the exercise of a Tandem SAR and unless otherwise determined by
the Board and provided in the applicable Agreement, (a) the Holder thereof shall be entitled to
receive from the Company, for each share of the applicable series of Common Stock with respect to
which the Tandem SAR is being exercised, consideration (in the form determined as provided in
Section 7.4) equal in value to the excess of the Fair Market Value of a share of the applicable
series of Common Stock with respect to which the Tandem SAR was granted on the date of exercise
over the related Option purchase price per share, and (b) the related Option with respect thereto
shall be canceled automatically to the extent of the number of shares of Common Stock with respect
to which the Tandem SAR was so exercised.

     7.3 Free Standing SARs. Free Standing SARs shall be exercisable at the time, to the extent and
upon the terms and conditions set forth in the applicable Agreement. The base price of a Free
Standing SAR may be no less than the Fair Market Value of the applicable series of Common Stock
with respect to which the Free Standing SAR was granted as of the date the Free Standing SAR is
granted. Subject to the limitations of the Plan, upon the exercise of a Free Standing SAR and
unless otherwise determined by the Board and provided in the applicable Agreement, the Holder
thereof shall be entitled to receive from the Company, for each share of the applicable series of
Common Stock with respect to which the Free Standing SAR is being exercised, consideration (in the
form determined as provided in Section 7.4) equal in value to the excess of
the Fair Market Value of a share of the applicable series of Common Stock with respect to which the
Free Standing SAR was granted on the date of exercise over the base price per share of such Free
Standing SAR.

-8-

 

     7.4 Consideration. The consideration to be received upon the exercise of a SAR by the Holder
shall be paid in the applicable series of Common Stock with respect to which the SAR was granted
(valued at Fair Market Value on the date of exercise of such SAR). No fractional shares of Common
Stock shall be issuable upon exercise of a SAR, and unless otherwise provided in the applicable
Agreement, the Holder will receive cash in lieu of fractional shares. Unless the Board shall
otherwise determine, to the extent a Free Standing SAR is exercisable, it will be exercised
automatically on its expiration date.

     7.5 Limitations. The applicable Agreement may provide for a limit on the amount payable to a
Holder upon exercise of SARs at any time or in the aggregate, for a limit on the time periods
during which a Holder may exercise SARs, and for such other limits on the rights of the Holder and
such other terms and conditions of the SAR, including a condition that the SAR may be exercised
only in accordance with rules and regulations adopted from time to time, as the Board may
determine. Unless otherwise so provided in the applicable Agreement, any such limit relating to a
Tandem SAR shall not restrict the exercisability of the related Option. Such rules and regulations
may govern the right to exercise SARs granted prior to the adoption or amendment of such rules and
regulations as well as SARs granted thereafter.

     7.6 Exercise. For purposes of this Article VII, the date of exercise of a SAR shall mean the
date on which the Company shall have received notice from the Holder of the SAR of the exercise of
such SAR (unless otherwise determined by the Board and provided in the applicable Agreement).

     7.7 Nontransferability. Unless otherwise determined by the Board and provided in the
applicable Agreement, (a) SARs shall not be transferable other than by will or the laws of descent
and distribution or pursuant to a Domestic Relations Order, and (b) except as otherwise required
pursuant to a Domestic Relations Order, SARs may be exercised during the lifetime of the Holder
thereof only by such Holder (or his or her court-appointed legal representative).

ARTICLE VIII

Restricted Shares

     8.1 Grant. Subject to the limitations of the Plan, the Board shall designate those eligible
persons to be granted Awards of Restricted Shares, shall determine the time when each such Award
shall be granted, shall determine whether shares of Common Stock covered by Awards of Restricted
Shares will be issued at the beginning or the end of the Restriction Period and whether Dividend
Equivalents will be paid during the Restriction Period in the event shares of the applicable series
of Common Stock are to be issued at the end of the Restriction Period, and shall designate (or set
forth the basis for determining) the Vesting Date or Vesting Dates for each Award of Restricted
Shares, and may prescribe other restrictions, terms and conditions applicable to the vesting of
such Restricted Shares in addition to those provided in the Plan. The Board shall determine the
price, if any, to be paid by the Holder for the Restricted Shares;
provided, however, that the issuance of Restricted Shares shall be made for at least the minimum
consideration necessary to permit such Restricted Shares to be deemed fully paid and nonassessable.
All determinations made by the Board pursuant to this Section 8.1 shall be specified in the
Agreement.

-9-

 

     8.2 Issuance of Restricted Shares at Beginning of the Restriction Period. If shares of the
applicable series of Common Stock are issued at the beginning of the Restriction Period, the stock
certificate or certificates representing such Restricted Shares shall be registered in the name of
the Holder to whom such Restricted Shares shall have been awarded. During the Restriction Period,
certificates representing the Restricted Shares and any securities constituting Retained
Distributions shall bear a restrictive legend to the effect that ownership of the Restricted Shares
(and such Retained Distributions), and the enjoyment of all rights appurtenant thereto, are subject
to the restrictions, terms and conditions provided in the Plan and the applicable Agreement. Such
certificates shall remain in the custody of the Company or its designee, and the Holder shall
deposit with the custodian stock powers or other instruments of assignment, each endorsed in blank,
so as to permit retransfer to the Company of all or any portion of the Restricted Shares and any
securities constituting Retained Distributions that shall be forfeited or otherwise not become
vested in accordance with the Plan and the applicable Agreement.

     8.3 Restrictions. Restricted Shares issued at the beginning of the Restriction Period shall
constitute issued and outstanding shares of the applicable series of Common Stock for all corporate
purposes. The Holder will have the right to vote such Restricted Shares, to receive and retain such
dividends and distributions, as the Board may designate, paid or distributed on such Restricted
Shares, and to exercise all other rights, powers and privileges of a Holder of shares of the
applicable series of Common Stock with respect to such Restricted Shares; except, that, unless
otherwise determined by the Board and provided in the applicable Agreement, (a) the Holder will not
be entitled to delivery of the stock certificate or certificates representing such Restricted
Shares until the Restriction Period shall have expired and unless all other vesting requirements
with respect thereto shall have been fulfilled or waived; (b) the Company or its designee will
retain custody of the stock certificate or certificates representing the Restricted Shares during
the Restriction Period as provided in Section 8.2; (c) other than such dividends and distributions
as the Board may designate, the Company or its designee will retain custody of all distributions
(“Retained Distributions”) made or declared with respect to the Restricted Shares (and such
Retained Distributions will be subject to the same restrictions, terms and vesting, and other
conditions as are applicable to the Restricted Shares) until such time, if ever, as the Restricted
Shares with respect to which such Retained Distributions shall have been made, paid or declared
shall have become vested, and such Retained Distributions shall not bear interest or be segregated
in a separate account; (d) the Holder may not sell, assign, transfer, pledge, exchange, encumber or
dispose of the Restricted Shares or any Retained Distributions or his interest in any of them
during the Restriction Period; and (e) a breach of any restrictions, terms or conditions provided
in the Plan or established by the Board with respect to any Restricted Shares or Retained
Distributions will cause a forfeiture of such Restricted Shares and any Retained Distributions with
respect thereto.

-10-

 

     8.4 Issuance of Stock at End of the Restriction Period. Restricted Shares issued at the end of
the Restriction Period shall not constitute issued and outstanding shares of the applicable series
of Common Stock, and the Holder shall not have any of the rights of a stockholder with respect to
the shares of Common Stock covered by such an Award of Restricted Shares, in each case until such
shares shall have been transferred to the Holder at the end of the Restriction Period. If and to
the extent that shares of Common Stock are to be issued at the end of the Restriction Period, the
Holder shall be entitled to receive Dividend Equivalents with respect to the shares of Common Stock
covered thereby either (a) during the Restriction Period or (b) in accordance with the rules
applicable to Retained Distributions, as the Board may specify in the Agreement.

     8.5 Cash Payments. In connection with any Award of Restricted Shares, an Agreement may provide
for the payment of a cash amount to the Holder of such Restricted Shares after such Restricted
Shares shall have become vested. Such cash amounts shall be payable in accordance with such
additional restrictions, terms and conditions as shall be prescribed by the Board in the Agreement
and shall be in addition to any other compensation payments which such Holder shall be otherwise
entitled or eligible to receive from the Company.

     8.6 Completion of Restriction Period. On the Vesting Date with respect to each Award of
Restricted Shares and the satisfaction of any other applicable restrictions, terms and conditions,
(a) all or the applicable portion of such Restricted Shares shall become vested, (b) any Retained
Distributions and any unpaid Dividend Equivalents with respect to such Restricted Shares shall
become vested to the extent that the Restricted Shares related thereto shall have become vested,
and (c) any cash amount to be received by the Holder with respect to such Restricted Shares shall
become payable, all in accordance with the terms of the applicable Agreement. Any such Restricted
Shares, Retained Distributions and any unpaid Dividend Equivalents that shall not become vested
shall be forfeited to the Company, and the Holder shall not thereafter have any rights (including
dividend and voting rights) with respect to such Restricted Shares, Retained Distributions and any
unpaid Dividend Equivalents that shall have been so forfeited. The Board may, in its discretion,
provide that the delivery of any Restricted Shares, Retained Distributions and unpaid Dividend
Equivalents that shall have become vested, and payment of any cash amounts that shall have become
payable, shall be deferred until such date or dates as the recipient may elect. Any election of a
recipient pursuant to the preceding sentence shall be filed in writing with the Board in accordance
with such rules and regulations, including any deadline for the making of such an election, as the
Board may provide, and shall be made in compliance with Section 409A of the Code.

ARTICLE IX

Stock Units

     9.1 Grant. In addition to granting Awards of Options, SARs and Restricted Shares, the Board
shall, subject to the limitations of the Plan, have authority to grant to eligible persons Awards
of Stock Units which may be in the form of shares of any specified series of Common Stock or units,
the value of which is based, in whole or in part, on the Fair Market Value of the shares of any
specified series of Common Stock. Subject to the provisions of the Plan, including any rules
established pursuant to Section 9.2, Awards of Stock Units shall be subject to such terms,
restrictions, conditions, vesting requirements and payment rules as the Board may determine in
its discretion, which need not be identical for each Award. The determinations made by the Board
pursuant to this Section 9.1 shall be specified in the applicable Agreement.

-11-

 

     9.2 Rules. The Board may, in its discretion, establish any or all of the following rules for
application to an Award of Stock Units:

     (a) Any shares of Common Stock which are part of an Award of Stock Units may not be assigned,
sold, transferred, pledged or otherwise encumbered prior to the date on which the shares are issued
or, if later, the date provided by the Board at the time of the Award.

     (b) Such Awards may provide for the payment of cash consideration by the person to whom such
Award is granted or provide that the Award, and any shares of Common Stock to be issued in
connection therewith, if applicable, shall be delivered without the payment of cash consideration;
provided, however, that the issuance of any shares of Common Stock in connection with an Award of
Stock Units shall be for at least the minimum consideration necessary to permit such shares to be
deemed fully paid and nonassessable.

     (c) Awards of Stock Units may relate in whole or in part to performance or other criteria
established by the Board at the time of grant.

     (d) Awards of Stock Units may provide for deferred payment schedules, vesting over a specified
period of service, the payment (on a current or deferred basis) of dividend equivalent amounts with
respect to the number of shares of Common Stock covered by the Award, and elections by the Holder
to defer payment of the Award or the lifting of restrictions on the Award, if any, provided that
any such deferrals shall comply with the requirements of Section 409A of the Code.

     (e) In such circumstances as the Board may deem advisable, the Board may waive or otherwise
remove, in whole or in part, any restrictions or limitations to which a Stock Unit Award was made
subject at the time of grant.

ARTICLE X

General Provisions

     10.1 Acceleration of Awards.

     (a) Death or Disability. If a Holder’s service shall terminate by reason of death or
Disability, notwithstanding any contrary waiting period, installment period, vesting schedule or
Restriction Period in any Agreement or in the Plan, unless the applicable Agreement provides
otherwise: (i) in the case of an Option or SAR, each outstanding Option or SAR granted under the
Plan shall immediately become exercisable in full in respect of the aggregate number of shares
covered thereby; (ii) in the case of Restricted Shares, the Restriction Period applicable to each
such Award of Restricted Shares shall be deemed to have expired and all such Restricted Shares, any
related Retained Distributions and any unpaid Dividend Equivalents shall become vested and any
related cash amounts payable pursuant to the applicable Agreement shall be adjusted in such
manner as may be provided in the Agreement; and (iii) in the case of Stock Units, each such Award
of Stock Units shall become vested in full.

-12-

 

     (b) Approved Transactions; Board Change; Control Purchase. In the event of any Approved
Transaction, Board Change or Control Purchase, notwithstanding any contrary waiting period,
installment period, vesting schedule or Restriction Period in any Agreement or in the Plan, unless
the applicable Agreement provides otherwise: (i) in the case of an Option or SAR, each such
outstanding Option or SAR granted under the Plan shall become exercisable in full in respect of the
aggregate number of shares covered thereby; (ii) in the case of Restricted Shares, the Restriction
Period applicable to each such Award of Restricted Shares shall be deemed to have expired and all
such Restricted Shares, any related Retained Distributions and any unpaid Dividend Equivalents
shall become vested and any related cash amounts payable pursuant to the applicable Agreement shall
be adjusted in such manner as may be provided in the Agreement; and (iii) in the case of Stock
Units, each such Award of Stock Units shall become vested in full, in each case effective upon the
Board Change or Control Purchase or immediately prior to consummation of the Approved Transaction.
Notwithstanding the foregoing, unless otherwise provided in the applicable Agreement, the Board
may, in its discretion, determine that any or all outstanding Awards of any or all types granted
pursuant to the Plan will not vest or become exercisable on an accelerated basis in connection with
an Approved Transaction if effective provision has been made for the taking of such action which,
in the opinion of the Board, is equitable and appropriate to substitute a new Award for such Award
or to assume such Award and to make such new or assumed Award, as nearly as may be practicable,
equivalent to the old Award (before giving effect to any acceleration of the vesting or
exercisability thereof), taking into account, to the extent applicable, the kind and amount of
securities, cash or other assets into or for which the applicable series of Common Stock may be
changed, converted or exchanged in connection with the Approved Transaction.

     10.2 Termination of Service.

     (a) General. If a Holder’s service shall terminate prior to an Option or SAR becoming
exercisable or being exercised (or deemed exercised, as provided in Section 7.2) in full, or during
the Restriction Period with respect to any Restricted Shares or prior to the vesting or complete
exercise of any Stock Units, then such Option or SAR shall thereafter become or be exercisable,
such Stock Units to the extent vested shall thereafter be exercisable, and the Holder’s rights to
any unvested Restricted Shares, Retained Distributions, unpaid Dividend Equivalents and related
cash amounts, and any such unvested Stock Units shall thereafter vest, in each case solely to the
extent provided in the applicable Agreement; provided, however, that, unless otherwise determined
by the Board and provided in the applicable Agreement, (i) no Option or SAR may be exercised after
the scheduled expiration date thereof; (ii) if the Holder’s service terminates by reason of death
or Disability, the Option or SAR shall remain exercisable for a period of at least one year
following such termination (but not later than the scheduled expiration of such Option or SAR); and
(iii) any termination of the Holder‘s service for cause will be treated in accordance with the
provisions of Section 10.2(b).

-13-

 

     (b) Termination for Cause. If a Holder’s service on the Board shall be terminated by the
Company for “cause” during the Restriction Period with respect to any Restricted Shares, or
prior to any Option or SAR becoming exercisable or being exercised in full or prior to the vesting
or complete exercise of any Stock Unit (for these purposes, “cause” shall include dishonesty,
incompetence, moral turpitude, other misconduct of any kind and the refusal to perform his duties
and responsibilities for any reason other than illness or incapacity; provided, however, that if
such termination occurs within 12 months after an Approved Transaction or Control Purchase or Board
Change, termination for “cause” shall mean only a felony conviction for fraud, misappropriation or
embezzlement), then, unless otherwise determined by the Board and provided in the applicable
Agreement, (i) all Options and SARs and all unvested or unexercised Stock Units held by such Holder
shall immediately terminate, and (ii) such Holder’s rights to all Restricted Shares, Retained
Distributions, any unpaid Dividend Equivalents and any related cash amounts shall be forfeited
immediately.

     10.3 Nonalienation of Benefits. Except as set forth herein, no right or benefit under the Plan
shall be subject to anticipation, alienation, sale, assignment, hypothecation, pledge, exchange,
transfer, encumbrance or charge, and any attempt to anticipate, alienate, sell, assign,
hypothecate, pledge, exchange, transfer, encumber or charge the same shall be void. No right or
benefit hereunder shall in any manner be liable for or subject to the debts, contracts, liabilities
or torts of the person entitled to such benefits.

     10.4 Written Agreement. Each Award of Options shall be evidenced by a stock option agreement;
each Award of SARs shall be evidenced by a stock appreciation rights agreement; each Award of
Restricted Shares shall be evidenced by a restricted shares agreement; and each Award of Stock
Units shall be evidenced by a stock units agreement, each in such form and containing such terms
and provisions not inconsistent with the provisions of the Plan as the Board from time to time
shall approve; provided, however, that if more than one type of Award is made to the same Holder,
such Awards may be evidenced by a single Agreement with such Holder. Each grantee of an Option,
SAR, Restricted Shares or Stock Units shall be notified promptly of such grant, and a written
Agreement shall be promptly executed and delivered by the Company. Any such Agreement may be
supplemented or amended from time to time as approved by the Board as contemplated by Section
10.6(b).

     10.5 Designation of Beneficiaries. Each person who shall be granted an Award under the Plan
may designate a beneficiary or beneficiaries and may change such designation from time to time by
filing a written designation of beneficiary or beneficiaries with the Board on a form to be
prescribed by it, provided that no such designation shall be effective unless so filed prior to the
death of such person.

     10.6 Termination and Amendment.

     (a) General. Unless the Plan shall theretofore have been terminated as hereinafter provided,
no Awards may be made under the Plan on or after the tenth anniversary of the Effective Date. The
Plan may be terminated at any time prior to the tenth anniversary of the Effective Date and may,
from time to time, be suspended or discontinued or modified or amended if such action is deemed
advisable by the Board.

-14-

 

     (b) Modification. No termination, modification or amendment of the Plan may, without the
consent of the person to whom any Award shall theretofore have been granted, adversely affect the
rights of such person with respect to such Award, except as otherwise permitted by Section 10.17.
No modification, extension, renewal or other change in any Award granted under the Plan shall be
made after the grant of such Award, unless the same is consistent with the provisions of the Plan.
With the consent of the Holder, or as otherwise permitted under Section 10.17, and subject to the
terms and conditions of the Plan (including Section 10.6(a)), the Board may amend outstanding
Agreements with any Holder, including any amendment which would (i) accelerate the time or times at
which the Award may be exercised and/or (ii) extend the scheduled expiration date of the Award.
Without limiting the generality of the foregoing, the Board may, but solely with the Holder’s
consent unless otherwise provided in the Agreement, agree to cancel any Award under the Plan and
grant a new Award in substitution therefor, provided that the Award so substituted shall satisfy
all of the requirements of the Plan as of the date such new Award is made. Nothing contained in the
foregoing provisions of this Section 10.6(b) shall be construed to prevent the Board from providing
in any Agreement that the rights of the Holder with respect to the Award evidenced thereby shall be
subject to such rules and regulations as the Board may, subject to the express provisions of the
Plan, adopt from time to time or impair the enforceability of any such provision.

     10.7 Government and Other Regulations. The obligation of the Company with respect to Awards
shall be subject to all applicable laws, rules and regulations and such approvals by any
governmental agencies as may be required, including the effectiveness of any registration statement
required under the Securities Act of 1933, and the rules and regulations of any securities exchange
or association on which the Common Stock may be listed or quoted. For so long as any series of
Common Stock are registered under the Exchange Act, the Company shall use its reasonable efforts to
comply with any legal requirements (a) to maintain a registration statement in effect under the
Securities Act of 1933 with respect to all shares of the applicable series of Common Stock that may
be issued to Holders under the Plan and (b) to file in a timely manner all reports required to be
filed by it under the Exchange Act.

     10.8 Withholding. The Company’s obligation to deliver shares of Common Stock or pay cash in
respect of any Award under the Plan shall be subject to applicable federal, state and local tax
withholding requirements. Federal, state and local withholding tax due at the time of an Award,
upon the exercise of any Option or SAR or upon the vesting of, or expiration of restrictions with
respect to, Restricted Shares or Stock Units, as appropriate, may, in the discretion of the Board,
be paid in shares of the applicable series of Common Stock already owned by the Holder or through
the withholding of shares otherwise issuable to such Holder, upon such terms and conditions
(including the conditions referenced in Section 6.5) as the Board shall determine. If the Holder
shall fail to pay, or make arrangements satisfactory to the Board for the payment to the Company
of, all such federal, state and local taxes required to be withheld by the Company, then the
Company shall, to the extent permitted by law, have the right to deduct from any payment of any
kind otherwise due to such Holder an amount equal to any federal, state or local taxes of any kind
required to be withheld by the Company with respect to such Award.

     10.9 Nonexclusivity of the Plan. The adoption of the Plan by the Board shall not be construed
as creating any limitations on the power of the Board to adopt such other incentive arrangements
as it may deem desirable, including the granting of stock options and the awarding of stock and
cash otherwise than under the Plan, and such arrangements may be either generally applicable or
applicable only in specific cases.

-15-

 

     10.10 Exclusion from Other Plans. By acceptance of an Award, unless otherwise provided in the
applicable Agreement, each Holder shall be deemed to have agreed that such Award is special
incentive compensation that will not be taken into account, in any manner, as compensation or bonus
in determining the amount of any payment under any pension, retirement or other benefit plan,
program or policy of the Company or any Subsidiary of the Company. In addition, each beneficiary of
a deceased Holder shall be deemed to have agreed that such Award will not affect the amount of any
life insurance coverage, if any, provided by the Company on the life of the Holder which is payable
to such beneficiary under any life insurance plan of the Company or any Subsidiary of the Company.

     10.11 Unfunded Plan. Neither the Company nor any Subsidiary of the Company shall be required
to segregate any cash or any shares of Common Stock which may at any time be represented by Awards,
and the Plan shall constitute an “unfunded” plan of the Company. Except as provided in Article VIII
with respect to Awards of Restricted Shares and except as expressly set forth in an Agreement, no
Holder shall have voting or other rights with respect to the shares of Common Stock covered by an
Award prior to the delivery of such shares. Neither the Company nor any Subsidiary of the Company
shall, by any provisions of the Plan, be deemed to be a trustee of any shares of Common Stock or
any other property, and the liabilities of the Company to any Holder pursuant to the Plan shall be
those of a debtor pursuant to such contract obligations as are created by or pursuant to the Plan,
and the rights of any Holder under the Plan shall be limited to those of a general creditor of the
Company. In its sole discretion, the Board may authorize the creation of trusts or other
arrangements to meet the obligations of the Company under the Plan, provided, however, that the
existence of such trusts or other arrangements is consistent with the unfunded status of the Plan.

     10.12 Governing Law. The Plan shall be governed by, and construed in accordance with, the laws
of the State of Delaware.

     10.13 Accounts. The delivery of any shares of Common Stock and the payment of any amount in
respect of an Award shall be for the account of the Company or the applicable Subsidiary of the
Company, as the case may be, and any such delivery or payment shall not be made until the recipient
shall have paid or made satisfactory arrangements for the payment of any applicable withholding
taxes as provided in Section 10.8.

     10.14 Legends. Each certificate evidencing shares of Common Stock subject to an Award shall
bear such legends as the Board deems necessary or appropriate to reflect or refer to any terms,
conditions or restrictions of the Award applicable to such shares, including any to the effect that
the shares represented thereby may not be disposed of unless the Company has received an opinion of
counsel, acceptable to the Company, that such disposition will not violate any federal or state
securities laws.

-16-

 

     10.15 Company’s Rights. The grant of Awards pursuant to the Plan shall not affect in any way
the right or power of the Company to make reclassifications, reorganizations or other changes of or
to its capital or business structure or to merge, consolidate, liquidate, sell or otherwise dispose
of all or any part of its business or assets.

     10.16 Interpretation. The words “include,” “includes,” “included” and “including” to the
extent used in the Plan shall be deemed in each case to be followed by the words “without
limitation.”

     10.17 Section 409A. Notwithstanding anything in this Plan to the contrary, if any Plan
provision or Award under the Plan would result in the imposition of an additional tax under Code
Section 409A and related regulations and United States Department of the Treasury pronouncements
(“Section 409A”), that Plan provision or Award will be reformed to avoid imposition of the
applicable tax and no action taken to comply with Section 409A shall be deemed to adversely affect
the Holder’s rights to an Award or require the consent of the Holder.

-17-exv10w1

Exhibit 10.1

IRREVOCABLE WAIVER AND TERMINATION AGREEMENT

     THIS IRREVOCABLE WAIVER AND TERMINATION AGREEMENT (this “Termination Agreement”) is executed
and delivered on October 14, 2008 by and between Endocare, Inc., a Delaware corporation
(“Endocare”), and Paul W. Mikus, an individual resident of the State of California (“Mikus”)
(together, the “Parties”).

     WHEREAS, Mikus was previously an employee and executive officer of Endocare; and

     WHEREAS, Mikus’s employment with Endocare was terminated in 2003 and Mikus ceased to serve as
an executive officer of Endocare in 2003; and

     WHEREAS, in connection with the termination of Mikus’s employment with Endocare, Mikus and
Endocare executed and delivered a Separation Agreement, dated July 31, 2003 (the “Separation
Agreement”), and a Consulting Agreement, dated July 31, 2003 (the “Consulting Agreement”); and

     WHEREAS, during Mikus’s employment with Endocare, Mikus and Endocare executed and delivered an
Indemnification Agreement, dated October 30, 2001 (the “Indemnification Agreement”); and

     WHEREAS, Mikus is currently a defendant in the criminal case captioned United States of
America v. Paul Mikus, et al. (Case No. CR07-0060 JVS) (the “Criminal Case”) and in the civil case
captioned Securities and Exchange Commission v. Paul W. Mikus and John V. Cracchiolo (Case No. SACV
06-734 JVS (MLGx)) (the “Civil Case”); and

     WHEREAS, pursuant to Section 11(a) of the Indemnification Agreement, Endocare has been
advancing Expenses (as defined in the Indemnification Agreement) on Mikus’s behalf in connection
with the Criminal Case and the Civil Case; and

     WHEREAS, on October 6, 2008, Mikus entered a guilty plea in the Criminal Case, pursuant to
which he will be required to pay restitution to Endocare; and

     WHEREAS, in connection with the termination of his employment, Endocare paid to Mikus a
severance amount (the “Severance Amount”) pursuant to Section 1 of the Separation Agreement and a
consulting fee (the “Consulting Fee”) pursuant to Section 2 of the Consulting Agreement; and

     WHEREAS, Section 1 of the Separation Agreement provides that Mikus shall be liable to repay to
Endocare the Severance Amount and Section 2(a) of the Consulting Agreement provides that Mikus
shall be liable to repay to Endocare the Consulting Fee, in each case upon either: (a) the
conviction of Mikus in a court of law, or entering a plea of guilty or no contest to, any crime
directly relating to Mikus’s activities on behalf of Endocare during his employment with Endocare;
or (b) successful prosecution of an

-1-

 

enforcement action by the Securities and Exchange Commission against Mikus directly relating
to Mikus’s activities as an employee and executive officer of Endocare; and

     WHEREAS, Section 11 of the Indemnification Agreement provides that Mikus shall reimburse
Endocare for all Expenses advanced by Endocare in certain circumstances; and

     WHEREAS, Endocare is willing to irrevocably waive its repayment and reimbursement rights under
the Separation Agreement, Consulting Agreement and the Indemnification Agreement if Mikus agrees to
terminate the Indemnification Agreement in its entirety and to irrevocably waive and release any
right to have Endocare pay any Expenses or other amounts incurred on or after July 31, 2008;

     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, Endocare and Mikus hereby agree as follows:

     1. Termination of Endocare Severance Recapture Rights. Effective July 31, 2008, the
third sentence of Section 1 of the Separation Agreement and the second sentence of Section 2(a) of
the Consulting Agreement are hereby terminated in their entirety and rendered of no further force
or effect whatsoever. Effective July 31, 2008, Endocare hereby irrevocably waives any right to
receive repayment of the Severance Amount and the Consulting Fee.

     2. Termination of Indemnification Agreement. Effective July 31, 2008, the
Indemnification Agreement is hereby terminated and rendered of no further force or effect
whatsoever. Effective July 31, 2008, neither Party shall have any further rights or obligations
under the Indemnification Agreement whatsoever; provided, however, that Endocare
shall be required to advance any Expenses incurred under the Indemnification Agreement on or prior
to July 31, 2008.

     3. Waiver and Release of Any Advancement or Indemnification Rights. Except as set
forth in paragraph 4, below, effective July 31, 2008, Mikus hereby irrevocably waives, releases,
relinquishes and discharges any and all claims or rights he may have to advancement,
indemnification or other payment rights whatsoever under Endocare’s current or former bylaws, its
Certificate of Incorporation, any statute (including but not limited to California Corporations
Code Section 317 and Section 145 of the Delaware General Corporation Law), any principle of law or
otherwise. Endocare shall have no obligation whatsoever to advance, reimburse or indemnify against
any Expenses or other amounts incurred on or after July 31, 2008 or make any payments to or for the
benefit of Mikus in connection with any Proceeding (as defined in the Indemnification Agreement),
including but not limited to the Criminal Case and the Civil Case. Endocare asserts that Mikus is
not entitled to indemnification under California Labor Code Section 2802. Mikus hereby agrees not
to seek any indemnification whatsoever from Endocare under California Labor Code Section 2802 or
any other provision of law providing rights to Mikus that may not be waiveable. In the event that
Mikus at any time seeks any such indemnification and is determined to be entitled to such
indemnification, then Mikus
agrees that Endocare shall be entitled to offset the Severance Amount and the Consulting Fee
against any such indemnification amounts, notwithstanding Section 1 above.

-2-

 

     4. Limited Payment of Expenses Incurred between August 1, 2008 and September 30,
2008. Notwithstanding paragraph 3, above, Endocare agrees to pay Expenses incurred by Mikus
between August 1, 2008 and September 30, 2008 (the “Limited Payment Period”), to be paid
exclusively from the proceeds to Endocare of any restitution payment made by Mikus to Endocare (the
“Endocare Restitution Payment”) and up to a maximum of $510,000.

          a. If Mikus does not pay the Endocare Restitution Payment, Endocare shall not be responsible
to pay any Expenses incurred by Mikus during the Limited Payment Period and this paragraph 4 shall
be null and void.

          b. If the Endocare Restitution Payment is $510,000 or more, Endocare shall be responsible to
pay Expenses incurred by Mikus during the Limited Payment Period, up to the lesser of the Expenses
incurred during the Limited Payment Period or $510,000.

          c. Regardless of the amount of the Endocare Restitution Payment, Endocare shall have no
responsibility for any Expenses exceeding the lesser of $510,000 or the Endocare Restitution
Payment.

     5. Timing of Payment of Expenses. Within 7 days of its receipt of a fully executed
copy of this Termination Agreement, Endocare shall pay the following Expenses for costs, attorney’s
fees and expert fees invoiced for amounts incurred through July 31, 2008: (a) $141,503.85 due to
Bienert, Miller, Weitzel & Katzman for services rendered through July 31, 2008; (b) $121,106.00 due
to Hemming Morse, Inc. for services rendered through July 31, 2008; and (c) $1,839.91 for services
rendered by an undisclosed expert witness through July 31, 2008, to be paid in care of Bienert,
Miller, Weitzel & Katzman. Any Expenses owed by Endocare for the Limited Payment Period, pursuant
to paragraph 4 above, shall be paid within 10 days of Endocare’s receipt and deposit of the
Endocare Restitution Payment.

     6. Restitution, Disgorgement or Other Remedies Imposed Upon Mikus. Nothing in this
Termination Agreement shall affect in any way Mikus’s obligations under any judgment or settlement
in the Criminal Case or Civil Case, or the relief that may be imposed or remedies that may be
ordered as part of the judgment of the Criminal Case, a settlement or judgment in the Civil Case or
in any other legal proceeding brought by a party other than Endocare and to which Mikus is or may
hereafter be a party. By way of example, should Mikus be ordered to pay restitution to Endocare in
the judgment concluding the Criminal Case, Mikus shall be obligated to comply with that judgment,
notwithstanding this Termination Agreement and even if he is ordered to pay more than $510,000 in
restitution.

     7. Miscellaneous. This Termination Agreement shall be governed by the laws of the
State of California, without regard to conflict of laws principles. This Termination Agreement may
be executed in one or more counterparts, each of which shall be deemed an original and all of which
taken together shall be deemed to be one instrument. Any
facsimile or electronic signature of this Termination Agreement (such as .pdf format) shall be
valid for all purposes.

-3-

 

     8. Third-Party Beneficiary. The parties recognize and agree that this Agreement,
including paragraph 5 above, is made expressly for the benefit not only of the Parties but also of
the law firm of Bienert, Miller, Weitzel & Katzman, which shall have the right to pursue any and
all remedies available to it under California law in the event of any breach of this Agreement.

     9. Binding on Successors and Assigns. This Termination Agreement shall apply to
Endocare and Mikus, as well as their respective predecessors, successors, parents, subsidiaries,
affiliates, custodians, agents, assigns, representatives, heirs, estates, executors, trusts,
trustees, trust beneficiaries, administrators, spouses, marital communities, and immediate family
members.

Signature Page Follows

-4-

 

     IN WITNESS WHEREOF, Endocare and Mikus hereby execute and deliver this Irrevocable Waiver and
Termination Agreement.

	 	 	 	 	 	 	 
	 	 	ENDOCARE, INC.
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Clint B. Davis	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Clint B. Davis 

General Counsel	 	 
	 
	 	 	 	 	 	 
	 	 	PAUL W. MIKUS:
	 
	 	 	 	 	 	 
	 

	 	 	 	/s/ Paul W. Mikus	 	 
	 	 	 	 	 
	 

	 	 	 	Paul W. Mikus	 	 

	 	 	 
	Approved as to form:
	 	 
	 
	 	 
	/s/ Thomas Bienert
 

Thomas Bienert

	 	 
	Bienert, Miller, Weitzel & Katzman
	 	 
	Attorneys for Paul W. Mikus
	 	 

[SIGNATURE PAGE TO IRREVOCABLE WAIVER

AND TERMINATION AGREEMENT]

-5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00148-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00148-of-00352.parquet"}]]